Oral health/diabetes campaign
This article was originally published in The Tan Sheet
Executive SummaryColgate-Palmolive partners with the American Diabetes Association to educate medical professionals and diabetes patients about the link between oral health and diabetes, the firm announces April 14. Emerging research suggests "not only are people with diabetes more susceptible to periodontal disease, but the presence of gum disease may have the potential to affect blood glucose control and contribute to the progression of diabetes," Colgate says. The multi-year educational campaign will include a new oral care section on ADA's Web site as well as "Ask the Dentist" - an online chat series, "Interactive Oral Hygiene" - an oral health quiz and patient education materials. Colgate and ADA also will conduct a joint symposium for health care professionals on diabetes and periodontal disease at the 2008 American Diabetes Association Scientific Sessions, the firm says...
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.